--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
APGE Apogee Therapeutics
- 47.710
- +0.690+1.47%
Close Dec 20 16:00 ET
- 47.710
- 0.0000.00%
Post 20:01 ET
2.79BMarket Cap-18.51P/E (TTM)
48.420High45.510Low606.24KVolume46.480Open47.020Pre Close28.82MTurnover2.08%Turnover RatioLossP/E (Static)58.51MShares72.29052wk High3.80P/B1.39BFloat Cap27.05052wk Low--Dividend TTM29.10MShs Float72.290Historical High--Div YieldTTM6.19%Amplitude14.190Historical Low47.538Avg Price1Lot Size
Apogee Therapeutics Key Stats
Apogee Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Apogee Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data